Monday, June 15, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

AST SpaceMobile’s Orbital Test: The Satellites That Must Deliver on $1.2 Billion in Carrier Promises

Kennethcix by Kennethcix
June 15, 2026
in Analysis, Space, Tech & Software, Telecommunications
0
AST SpaceMobile Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

The countdown clock at Cape Canaveral will tick past 2:39 a.m. EDT this week, and with it the fate of AST SpaceMobile’s entire commercial narrative. Three BlueBird satellites — numbers 8, 9 and 10 — sit atop a SpaceX Falcon 9, each carrying a 223-square-metre communications antenna that is supposed to transform all-in satellite connectivity from a pilot into a real business.

It is a mission loaded with weight that goes far beyond the payload’s mass. The company, valued at €27.63 billion, generated just $14.7 million in first-quarter revenue and posted a net loss of $191 million, or $0.66 per share. Analysts had expected more — the revenue miss was roughly 60%. Yet management insists the full-year target of $150 million to $200 million remains intact, roughly half of it already covered by secured backlog. The gap between those numbers and a market capitalisation of nearly €28 billion is the entire investment thesis in a nutshell.

That thesis rests on a single operational pivot: getting 45 to 60 BlueBird satellites into orbit by the end of 2026 to enable continuous SpaceMobile service in key markets — the U.S., Europe, Japan, India, Brazil and others. The production line is already running at six fully built BlueBirds per month. But the launch side has been less reliable. In April, BlueBird 7 failed to reach its intended orbit and had to be deorbited. Now three satellites are going up together, and another failure would not only delay the constellation but almost certainly send the stock reeling again.

Shares already sit around €71–74, roughly 35–38% below the 52-week high of €114.60 set in May. The recent slide accelerated after a seven-day, nearly 11% drop triggered by the SpaceX initial public offering, which put pressure across the space sector. On June 12 alone, approximately 54 million shares changed hands — 172% above the three-month average — underscoring the force of the selloff. Two banks piled on within days: Barclays cut its price target to $60 and kept an Underweight rating, while Deutsche Bank downgraded the stock from Buy to Hold, citing the Blue Origin New Glenn explosion as a potential risk to launch schedules.

That last point is critical. A rival rocket failure can ripple into AST SpaceMobile’s timeline if alternative launchers become scarce. For now, the company is relying on Falcon 9, and the immediate test is whether BlueBirds 8, 9 and 10 make it to their target orbit.

Should investors sell immediately? Or is it worth buying AST SpaceMobile?

Contracts Are Signed, Cash Is in the Bank

Despite the near-term noise, the structural argument for AST SpaceMobile has rarely been stronger. Nearly 60 global mobile operators — including Vodafone, Rakuten, Bell Canada, Telus and Saudi Telecom — have committed more than $1.2 billion in contractual revenue. Saudi Telecom alone signed a ten-year deal for direct-to-device services in Saudi Arabia and adjacent markets, accompanied by a $175 million prepayment for future services. Those partners cover a combined subscriber base of more than three billion people.

In the U.S., the three largest carriers — AT&T, T-Mobile and Verizon — recently announced a joint venture to accelerate direct-to-device technology and close coverage gaps. AT&T CEO John Stankey publicly confirmed that his company intends to continue working with AST SpaceMobile beyond the joint venture, an explicit endorsement from one of the industry’s most powerful executives.

The Federal Communications Commission has already granted commercial approval for SpaceMobile service in the U.S., with a network capacity of up to 248 satellites. And the technology has proved it can work: a Block 1 BlueBird satellite achieved peak data rates of 98.9 Mbps over international waters.

Enough Fuel to Finish the Job

Financially, the company is well-stocked. It holds roughly $3.5 billion in liquidity, enough to fund the planned constellation of about 90 satellites entirely from existing capital. The production line is humming, the carrier relationships are locked in, and the commercial launch window in the U.S. is open.

What remains is execution — and the unforgiving physics of orbital mechanics. The launch this week is the clearest signal yet that AST SpaceMobile is moving from PowerPoint to payload. Whether the stock can close the distance to its 52-week high depends on whether those three BlueBirds reach their designated orbit, and whether the second quarter finally produces the commercial revenue that the first quarter conspicuously failed to deliver.

Ad

AST SpaceMobile Stock: Buy or Sell?! New AST SpaceMobile Analysis from June 15 delivers the answer:

The latest AST SpaceMobile figures speak for themselves: Urgent action needed for AST SpaceMobile investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 15.

AST SpaceMobile: Buy or sell? Read more here...

Tags: AST SpaceMobile
Kennethcix

Kennethcix

Related Posts

Adobe Stock
AI & Quantum Computing

Adobe’s $500M AI Milestone Can’t Hide the Quiet ARR Revision That’s Spooking Investors

June 15, 2026
Outlook Therapeutics Stock
Analysis

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

June 15, 2026
IonQ Stock
AI & Quantum Computing

IonQ’s Nine-Code Feat Highlights Quantum Hardware Edge, but Shareholder Vote Looms Large

June 15, 2026
Next Post
Outlook Therapeutics Stock

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

Northern Resources Stock

Northern Star Rides Gold Wave as Activist Pressure Mounts

Adobe Stock

Adobe’s $500M AI Milestone Can’t Hide the Quiet ARR Revision That’s Spooking Investors

Recommended

American Express Stock

American Express Doubles Down on Premium Strategy with Card Revamp and Partnerships

9 months ago
Nvidia Stock

Nvidia Stock: China Shift Sparks Investor Concerns

10 months ago
Walgreens Stock

Walgreens Ownership Shift Sparks Industry Transformation

7 months ago
Axon Enterprise Stock

Axon Enterprise’s Bold AI Acquisition Rattles Investors

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

AST SpaceMobile’s Orbital Test: The Satellites That Must Deliver on $1.2 Billion in Carrier Promises

Qualcomm Faces a Defining Moment on June 24 as Data Center Ambitions and AI-PC Dominance Converge

Peace Deal, New Fed Chair, and the Broadening Trade

IonQ’s Nine-Code Feat Highlights Quantum Hardware Edge, but Shareholder Vote Looms Large

The Regress Trap: Why German Employers Who Skip Workplace Safety Inspections Risk Financial Ruin

Trending

Silber Preis Stock
Commodities

Peace Pact Reverses Silver’s 40% Slide, Lifting the Metal Above $70 on Rate and Industry Hopes

by SiterGedge
June 15, 2026
0

A dramatic turnaround in the Middle East has pulled silver out of a five-week tailspin. The agreement...

Adobe Stock

Adobe’s $500M AI Milestone Can’t Hide the Quiet ARR Revision That’s Spooking Investors

June 15, 2026
Northern Resources Stock

Northern Star Rides Gold Wave as Activist Pressure Mounts

June 15, 2026
Outlook Therapeutics Stock

Outlook Therapeutics Insider Bets $5 Million as FDA Clears Path for Eye Drug

June 15, 2026
AST SpaceMobile Stock

AST SpaceMobile’s Orbital Test: The Satellites That Must Deliver on $1.2 Billion in Carrier Promises

June 15, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Peace Pact Reverses Silver’s 40% Slide, Lifting the Metal Above $70 on Rate and Industry Hopes
  • Adobe’s $500M AI Milestone Can’t Hide the Quiet ARR Revision That’s Spooking Investors
  • Northern Star Rides Gold Wave as Activist Pressure Mounts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com